Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT studyEric Van Cutsem, David Cunningham, Scott Berry et al.|Annals of Oncology|2009Cited by 534